| Literature DB >> 22253751 |
Franco Mongini1, Andrea Evangelista, Chantal Milani, Luca Ferrero, Giovannino Ciccone, Alessandro Ugolini, Alessandro Piedimonte, Monica Sigaudo, Elisa Carlino, Emanuela Banzatti, Claudia Galassi.
Abstract
BACKGROUND: Noninvasive physical management is often prescribed for headache and neck pain. Systematic reviews, however, indicate that the evidence of its efficacy is limited. Our aim was to evaluate the effectiveness of a workplace educational and physical program in reducing headache and neck/shoulder pain. METHODOLOGY/PRINCIPALEntities:
Mesh:
Year: 2012 PMID: 22253751 PMCID: PMC3253792 DOI: 10.1371/journal.pone.0029637
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Flow chart.
Department and worker characteristics of the analyzed population.
| InterventionGroup | ControlGroup | Total | |
| Departments | (N = 119) | (N = 117) | (N = 236) |
| Size of department, median (range) | 5 (1–86) | 4 (1–133) | 4 (1–133) |
| Administrative Departments | 52 (44%) | 52 (44%) | 104 (44%) |
| Traffic Police Departments | 15 (13%) | 9 (8%) | 24 (10%) |
| Educational Departments | 52 (44%) | 56 (48%) | 108 (46%) |
Data are median (IQR) and n (%) unless otherwise indicated.
TTH = tension-type headache, M = migraine, MP = myogenous neck/shoulder pain.
Comparison of the proportion of subjects with (“improved”*) or without (“not improved” ‡) reduction in pain frequency or drug consumption of ≥50% at the end of follow-up (responder rates), between IG and control group.
| Intervention Group | Control Group | RR (95%CI) | RR (95%CI) | ||
| (N = 909) | (N = 972) | Crude | Adjusted | ||
| Headache | Not Improved | 672 (74%) | 817 (84%) | 1 | 1 |
| Improved | 237 (26%) | 155 (16%) | 1.58 (1.28, 1.92) | 1.58 (1.32, 1.87) | |
| Neck/shoulder pain | Not Improved | 636 (70%) | 788 (81%) | 1 | 1 |
| Improved | 273 (30%) | 184 (19%) | 1.53 (1.27, 1.82) | 1.53 (1.28, 1.82) | |
| Headache and/or Neck/shoulder pain | Not Improved | 590 (65%) | 793 (82%) | 1 | 1 |
| Improved | 319 (35%) | 179 (18%) | 1.82 (1.52, 2.15) | 1.83 (1.54, 2.14) | |
| Analgesic Drug consumption | Not Improved | 790 (87%) | 874 (90%) | 1 | 1 |
| Improved | 119 (13%) | 98 (10%) | 1.45 (1.05, 1.97) | 1.45 (1.03, 1.99) |
*“Improved”: subjects with a baseline frequency of ≥4 days/month with pain (or drug consumption) that had a reduction in pain frequency or drug consumption of ≥50% at the end of follow-up.
“Not improved”: includes subjects with ≥4 days/month with pain (or drug consumption) at the baseline with less than 50% of reduction in pain frequency or drug consumption at the end of follow-up, and those subjects that had a baseline frequency of less than 4 days with pain/drug consumption independently from their results.
adjusted by age, sex, neck/shoulder pain (when analyzing headache and analgesic drug consumption), headache (when analyzing neck/shoulder pain and analgesic drug consumption), education level, job activity and baseline value of each subject.
Effects of the intervention (change from baseline in the number of days with pain or drug consumption at month 7) on the study outcomes.
| Intervention Group (N = 909) | Control Group (N = 972) | Between group differences (Intervention vs Control) | |||||
| Baseline(mean) | Within group difference(mean, 95%CI) | Baseline(mean) | Within group difference(mean, 95%CI) | Crude(mean, 95%CI) | Adjusted | ||
| Headache | Days with headache, mean | 7.42 | −2.53 (−3.01, −2.04) | 7.28 | −0.81 (−1.29, −0.33) | −1.72 (−2.40, −1.04) | −1.63 (−2.20, −1.07) |
| among subjects with at least 4 days/month with headache | 12.00 | −4.70 (−5.44, −3.96) | 12.11 | −2.47 (−3.21, −1.72) | −2.23 (−3.28, −1.18) | −2.15 (−3.10, −1.21) | |
| Headache Index (FxI) | 0.56 | −0.17 (−0.21, −0.14) | 0.56 | −0.03 (−0.07, 0.00) | −0.14 (−0.19, −0.09) | −0.14 (−0.19, −0.10) | |
| among subjects with at least 4 days/month with headache | 0.90 | −0.33 (−0.40, −0.27) | 0.92 | −0.15 (−0.21, −0.08) | −0.19 (−0.28, −0.09) | −0.19 (−0.27, −0.10) | |
| Neck/shoulder pain | Days with neck/shoulder pain, mean | 11.23 | −3.23 (−3.97, −2.50) | 10.80 | −0.72 (−1.46, 0.02) | −2.51 (−3.56, −1.47) | −2.40 (−3.34, −1.47) |
| among subjects with at least 4 days/month with neck/shoulder pain | 17.78 | −6.15 (−7.26, −5.04) | 17.63 | −2.88 (−4.00, −1.76) | −3.27 (−4.85, −1.70) | −3.30 (−4.70, −1.89) | |
| Neck/shoulder pain Index (FxI) | 0.80 | −0.27 (−0.33, −0.22) | 0.75 | −0.02 (−0.08, 0.03) | −0.25 (−0.33, −0.17) | −0.23 (−0.31, −0.15) | |
| among subjects with at least 4 days/month with neck/shoulder pain | 1.27 | −0.21 (−0.27, −0.16) | 1.23 | −0.06 (−0.12, −0.01) | −0.36 (−0.48, −0.23) | −0.34 (−0.45, −0.22) | |
| Headache and/orNeck/shoulder pain | Days with headache and/or neck/shoulder pain, mean | 13.84 | −3.93 (−4.64, −3.21) | 13.61 | −1.28 (−2.00, −0.56) | −2.65 (−3.66, −1.63) | −2.57 (−3.52, −1.63) |
| among subjects with at least 4 days/month with headache and/or neck/shoulder pain | 17.04 | −5.41 (−6.26, −4.57) | 17.30 | −2.33 (−3.19, −1.47) | −3.08 (−4.29, −1.87) | −3.29 (−4.39, −2.18) | |
| Analgesic Drug consumption | Days with analgesic drug consumption, mean | 3.02 | −0.87 (−1.19, −0.55) | 2.94 | −0.38 (−0.70, −0.06) | −0.49 (−0.94, −0.03) | −0.43 (−0.77, −0.08) |
| among subjects with at least 4 days/month with analgesic drug consumption | 9.55 | −4.70 (−5.63, −3.76) | 9.78 | −3.98 (−4.93, −3.03) | −0.72 (−2.05, 0.62) | −0.83 (−1.95, 0.28) | |
*Adjusted by age, sex, neck/shoulder pain (when analyzing headache and analgesic drug consumption), headache (when analyzing neck/shoulder pain and analgesic drug consumption), education level, and job activity.
Figure 2Mean differences (days/month) between groups in the changes from baseline (month 7 vs. month 1) of the frequency of headache (panel A), neck/shoulder pain (panel B), headache and/or neck/shoulder pain (panel C), by subgroups.
Results (responder rates) of the sensitivity analyses performed on the whole randomized population according to two different scenarios.
|
|
| ||||||
| Intervention Group | Control Group | RR (95%CI) | Intervention Group | Control Group | RR (95%CI) | ||
| (N = 1457) | (N = 1438) | (N = 1457) | (N = 1438) | ||||
| Headache | Not Improved | 1132 (78%) | 1208 (84%) | 1 | 1132 (78%) | 1162 (81%) | 1 |
| Improved | 325 (22%) | 230 (16%) | 1.39 (1.20, 1.62) | 325 (22%) | 276 (19%) | 1.16 (1.01, 1.34) | |
| Neck/shoulder pain | Not Improved | 1080 (74%) | 1165 (81%) | 1 | 1080 (74%) | 1114 (77%) | 1 |
| Improved | 377 (26%) | 273 (19%) | 1.36 (1.19, 1.56) | 377 (26%) | 324 (23%) | 1.15 (1.01, 1.31) | |
| Headache and/orNeck/shoulder pain | Not Improved | 1039 (71%) | 1175 (82%) | 1 | 1039 (71%) | 1096 (76%) | 1 |
| Improved | 418 (29%) | 263 (18%) | 1.57 (1.37, 1.80) | 418 (29%) | 342 (24%) | 1.21 (1.07, 1.36) | |
| Analgesic Drug consumption | Not Improved | 1283 (88%) | 1293 (90%) | 1 | 1283 (88%) | 1279 (89%) | 1 |
| Improved | 174 (12%) | 145 (10%) | 1.18 (0.96, 1.46) | 174 (12%) | 159 (11%) | 1.08 (0.88, 1.32) | |
*Scenario 1: the probability of improvement observed in the control group was assigned to the workers not completing the baseline and/or the follow-up diary in both the IG and the control group.
**Scenario 2 (worst scenario): the probability of improvement observed in the IG was assigned to the workers not completing the baseline and/or the follow-up diary in the control group, whereas the probability of improvement observed in the control group was assigned to the workers not completing the baseline and/or the follow-up diary in the IG.